These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2971180)
1. [Effect of an immunomodulator, RU 41740, on experimental infections]. Joly V Presse Med; 1988 Jul; 17(28):1430-2. PubMed ID: 2971180 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of RU 41740, a bacterial immunomodulator, against experimental infections: induction of cytokine and immunoglobulin release in mice after oral administration. Nimier K; Wolff F; Allouch PY; Guy-Grand D; Bloy C Int J Immunopharmacol; 1999 Sep; 21(9):561-74. PubMed ID: 10501625 [TBL] [Abstract][Full Text] [Related]
3. Co-administration of immunomodulator tuftsin and liposomised nystatin can combat less susceptible Candida albicans infection in temporarily neutropenic mice. Khan MA; Nasti TH; Saima K; Mallick AI; Firoz A; Wajahul H; Ahmad N; Mohammad O FEMS Immunol Med Microbiol; 2004 Jul; 41(3):249-58. PubMed ID: 15196575 [TBL] [Abstract][Full Text] [Related]
4. The effects of RU 41.740, a glycoprotein immunomodulating agent derived from Klebsiella pneumoniae, on intra-abdominal abscess formation in mice. Finlay-Jones JJ; Boyden AN; Tillett EJ; Hart PH; Spencer LK; Reznikov M; McDonald PJ J Med Microbiol; 1993 Jun; 38(6):454-8. PubMed ID: 8510139 [TBL] [Abstract][Full Text] [Related]
5. [Determination of the anti-infective action of an immunomodulator. Biostim as an example]. Ounis I Allerg Immunol (Paris); 1991 Apr; 23(4):145-52. PubMed ID: 2069688 [TBL] [Abstract][Full Text] [Related]
6. RU-41740 (K. pneumoniae glycoprotein) enhances resistance to experimental candidiasis and stimulates phagocytic functions. Smets P; Salles MF; Rommain M; Zalisz R; Yagello M; Guenounou M Ann Inst Pasteur Immunol; 1987; 138(3):425-36. PubMed ID: 3307833 [TBL] [Abstract][Full Text] [Related]
7. Determination of the antiinfectious activity of RU 41740 (Biostim) as an example of an immunomodulator. Ounis I Adv Exp Med Biol; 1992; 319():165-74. PubMed ID: 1414591 [TBL] [Abstract][Full Text] [Related]
8. Thalidomide modulation of the immune response in female B6C3F1 mice: a host resistance study. Karrow NA; Guo TL; Zhang LX; McCay JA; Musgrove DL; Peachee VL; Germolec DR; White KL Int Immunopharmacol; 2003 Oct; 3(10-11):1447-56. PubMed ID: 12946441 [TBL] [Abstract][Full Text] [Related]
9. [Immunotolerance of RU 41740]. Gepner P Presse Med; 1988 Jul; 17(28):1458-60. PubMed ID: 2971187 [TBL] [Abstract][Full Text] [Related]
11. Retention of amphotericin-B therapeutic efficacy at half doses by synergistic activation of phagocytes. Cornaglia-Ferraris P; Rossi E; Perezzani L; Stradi R Cancer Detect Prev; 1991; 15(4):327-9. PubMed ID: 1794140 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of PSK, a protein-bound polysaccharide preparation against candidiasis in tumor-bearing mice. Uetsuka A; Satoh S; Ohno Y Adv Exp Med Biol; 1979; 121B():21-31. PubMed ID: 546134 [TBL] [Abstract][Full Text] [Related]
13. Studies on the mechanism of protodyne-induced protection against microbial infections. Berger FM; Fukui GM; Gustafson RH; Rosselet JP Proc Soc Exp Biol Med; 1971 Nov; 138(2):391-5. PubMed ID: 4330232 [No Abstract] [Full Text] [Related]
14. Cytokine-induced resistance to microbial infections in normal, immunosuppressed and bone marrow transplanted mice. Leshem B; Dekel R; Bercovier H; Tchakirov R; Polacheck I; Zakay-Rones Z; Schlesinger M; Kedar E Bone Marrow Transplant; 1992 Jun; 9(6):471-7. PubMed ID: 1628132 [TBL] [Abstract][Full Text] [Related]
15. [Immunostimulating properties of an extract isolated from Aloe vahombe. 2. Protection in mice by fraction F1 against infections by Listeria monocytogenes, Yersinia pestis, Candida albicans and Plasmodium berghei]. Brossat JY; Ledeaut JY; Ralamboranto L; Rakotovao LH; Solar S; Gueguen A; Coulanges P Arch Inst Pasteur Madagascar; 1981; 48(1):11-34. PubMed ID: 7044327 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection. Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189 [TBL] [Abstract][Full Text] [Related]
17. [The antiviral activity of peptide immunomodulator "Gepon" in experimental infections caused by herpes simplex viruses types 1 and 2]. Barinskiĭ IF; Alimbarova LM; Lazarenko AA; Ataullakhanov RI Vopr Virusol; 2003; 48(5):30-3. PubMed ID: 14598478 [TBL] [Abstract][Full Text] [Related]
18. [Prevention of infections of the respiratory tract in children with RU 41740]. Bonfils P Presse Med; 1988 Jul; 17(28):1450-2. PubMed ID: 2971185 [TBL] [Abstract][Full Text] [Related]
19. Treatment of fungal and other opportunistic infections in immunocompromised patients. Wade JC Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282 [TBL] [Abstract][Full Text] [Related]
20. Route of administration may determine the biological effects of RU 41,740 (Biostim). Trapping of 99mTc-labelled human albumin colloids in mice. Jacobsson H; Viland H; Blomgren H Int J Immunopharmacol; 1993 Apr; 15(3):353-60. PubMed ID: 8505148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]